Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
TPG Private Equity Opportunities, L.P.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This disclosure provides the Fund's Transactional NAV calculation and per-unit NAV breakdown as of April 30, 2026, which is material to investors in determining the pricing and valuation of their units. While routine NAV reporting is standard for funds, the specific disclosure of valuation methodology, component breakdown, and per-unit NAV across multiple share classes affects investor assessment of their holdings' value and is appropriately disclosed under Item 8.01 as a material event for a fund registrant.
View raw filing on EDGAR →
Barings Private Credit Corp
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The filing discloses the net asset value per share ($20.06 as of April 30, 2026) and provides a material update on the status of an ongoing private offering of up to $4.5 billion in Common Stock, noting that 145.2 million shares have been issued for $2.99 billion to date with continued monthly sales planned. While this involves a dilutive issuance, the disclosure is primarily a status update on an ongoing offering rather than announcement of a new discrete issuance event, and the emphasis on NAV and offering progress does not fit cleanly into the dilutive_issuance category (which typically flags discrete private placements or PIPEs). The disclosure is material to investors assessing the company's capital structure and offering trajectory.
View raw filing on EDGAR →
Victoria's Secret & Co.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Victoria's Secret announced a ticker symbol change from an unspecified prior symbol to VSXY, effective June 2, 2026. While ticker changes are administrative in nature, this disclosure is material to investors as it affects how the security is identified and traded on the NYSE. The event does not fit the delisting_risk category (which concerns failure to maintain listing standards) but represents a significant corporate action that would affect investor ability to trade and track the stock.
View raw filing on EDGAR →
Finwise Bancorp
Other material
confidence 72%
filed 2026-05-21
Item 7.01
FinWise Bancorp announced approval of a share repurchase program via press release on May 21, 2026. While share repurchases are material to investors as they signal capital allocation, confidence in confidence, and management's view of valuation, this disclosure does not fit neatly into the specific taxonomy categories (it is not a dilutive issuance, exec compensation, or earnings release). The event is material but best classified as other_material given the absence of a dedicated repurchase program category.
View raw filing on EDGAR →
Blackstone Private Credit Fund
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This Item 8.01 disclosure reports the Fund's NAV per share as of April 30, 2026 ($24.06 across all classes), aggregate NAV of $45.2 billion, portfolio fair value of $79.0 billion, and debt outstanding of $37.1 billion, along with status of ongoing public and private offerings totaling $56.8 billion in consideration. While NAV reporting is routine for closed-end funds, the scale of the Fund's assets, leverage metrics (0.77x debt-to-equity), and the substantial ongoing capital raise activity would be material to investors assessing the Fund's size, financial position, and growth trajectory. This does not fit neatly into the more specific event categories (not earnings, M&A, impairment, covenant breach, or other defined events), making "other_material" the appropriate classification.
View raw filing on EDGAR →
Carvana Auto Receivables Trust 2026-P2
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This filing discloses the public issuance of multiple classes of Asset Backed Notes (Class A-1 through Class D) by Carvana Auto Receivables Trust 2026-P2, with the Registrant filing to satisfy an undertaking to provide legality and tax opinions. While the issuance itself is a material financing event, it does not fit neatly into the more specific categories (not a traditional M&A activity, not a dilutive equity issuance, not a restatement or going-concern disclosure). The materiality stems from the significant debt issuance and the formal legal opinions required to support it.
View raw filing on EDGAR →
Carvana Auto Receivables Trust 2026-P2
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This disclosure describes the entry into a securitization transaction involving the transfer of motor vehicle retail installment sales contracts (receivables) from Carvana to Carvana Receivables Depositor LLC, with subsequent issuance of publicly registered notes secured by those receivables. While this involves asset transfers and financing, it is structured as a securitization rather than a traditional M&A activity or debt covenant event. The filing of substantially final transaction documents under Regulation AB Item 1100(f) indicates a material financing/capital structure event that would affect investor assessment of the registrant's financial position and obligations.
View raw filing on EDGAR →
Kontoor Brands, Inc.
Other material
confidence 55%
filed 2026-05-21
Item 7.01
The filing discloses entry into a "Purchase Agreement" via press release on May 21, 2026, but the Item 7.01 disclosure provides no substantive details about the agreement's nature, counterparty, financial terms, or strategic significance. While the language "entry into the Purchase Agreement" suggests a material transaction, the absence of specifics prevents confident classification as M&A activity or another defined event type. This is classified as other_material because a purchase agreement typically signals material business activity, but the vague disclosure warrants the catch-all category pending review of the actual press release exhibit.
View raw filing on EDGAR →
Monroe Capital Income Plus Corp
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The filing discloses a dividend distribution of $0.071 per share declared by the board on May 21, 2026, along with the net asset value per share as of April 30, 2026 ($9.77). While dividend declarations are routine for closed-end funds and investment companies, this disclosure does not fit cleanly into the standard earnings_release category (no financial results or performance metrics provided) nor any other specific event type. The dividend announcement is material to shareholders as it affects distributions, but the Item 8.01 format and lack of comprehensive financial results suggest classification as other_material rather than earnings_release.
View raw filing on EDGAR →
Zentalis Pharmaceuticals, Inc.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Zentalis announced Phase 1b clinical trial data for azenosertib in combination with paclitaxel in platinum-resistant ovarian cancer patients, showing an ORR of 39.1% and median PFS of 7.3 months with a manageable safety profile. While this is a significant clinical milestone for a development-stage biopharmaceutical company whose viability depends substantially on azenosertib's success, it does not fit neatly into the standard 8-K event taxonomy (not an earnings release, M&A activity, restatement, or other specifically enumerated event). The disclosure is material to investors assessing the company's pipeline progress and drug candidate potential.
View raw filing on EDGAR →
Liberty Latin America Ltd.
Other material
confidence 45%
filed 2026-05-21
Item 3.03
Item 3.03 discloses a material modification to security holder rights, but the actual substance is incorporated by reference from Item 8.01 (Other Events), which is not provided. Without the underlying Item 8.01 content, the specific nature of the modification cannot be determined. The reference structure suggests a material event affecting security holders, but the event type cannot be reliably classified without the substantive disclosure.
View raw filing on EDGAR →
Liberty Latin America Ltd.
Other material
confidence 75%
filed 2026-05-21
Item 7.01
Liberty Latin America announced a special dividend consisting of newly issued preferred shares (9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preference Shares) at a 1-for-10 ratio to common shareholders. This is a material capital structure event affecting shareholder value and equity composition, but does not fit neatly into the standard taxonomy categories (not a typical cash dividend, not M&A, not an executive event). The issuance of new preferred shares with fixed dividend rights is material to investors assessing the company's capital structure and future cash obligations.
View raw filing on EDGAR →
Liberty Latin America Ltd.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Liberty Latin America has issued Series A Preference Shares with material terms including a 9.0% annual dividend accrual, liquidation preferences, optional redemption rights, and conditional director election rights triggered by dividend non-payment. This disclosure of a new class of preferred equity with significant economic and governance rights is material to investors' understanding of the company's capital structure and obligations, though it does not fit neatly into the standard 8-K event taxonomy (not a typical earnings release, M&A, restatement, or other enumerated event).
View raw filing on EDGAR →
SEACOR Marine Holdings Inc.
Other material
confidence 45%
filed 2026-05-21
Item 2.03
Item 2.03 discloses creation of a direct financial obligation, which typically signals material debt or financing activity. However, the section merely incorporates Item 1.01 by reference without disclosing the underlying obligation details. Without access to Item 1.01 content, the specific event type cannot be determined—it could be ma_activity (if Item 1.01 covers a material acquisition or merger), covenant_breach, or another material event. The materiality is presumed true given Item 2.03's regulatory significance, but the event classification remains ambiguous.
View raw filing on EDGAR →
SEACOR Marine Holdings Inc.
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The disclosure reports completion of sales of five vessels (two PSVs, one FSV, two liftboats) for $46.5 million gross proceeds, reducing the fleet from 43 to 38 vessels. While this represents a material disposition of assets and cash inflow, it does not fit cleanly into the ma_activity category (which typically covers acquisitions, mergers, or changes of control) nor any other specific event type. The sale is material to investors assessing the company's asset base and liquidity position.
View raw filing on EDGAR →
CLOUDASTRUCTURE, INC.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The Company disclosed via press release that it failed to file its Form 10-Q for Q1 2026 by the extended deadline of May 20, 2026. This is a material disclosure of non-compliance with SEC filing requirements that would affect investor assessment of the registrant's operational and regulatory standing. While this could signal delisting risk or other underlying issues, the disclosure itself centers on the filing delinquency rather than a specific delisting notice or going-concern statement.
View raw filing on EDGAR →
Chilean Cobalt Corp.
Other material
confidence 35%
filed 2026-05-21
Item 1.01
The filing references Item 1.01 (Entry into a Material Definitive Agreement), which typically signals M&A activity or a significant commercial contract. However, the provided text is incomplete — it cuts off mid-sentence at "To the extent required by this" — making it impossible to determine the specific nature of the agreement or whether it constitutes an acquisition, disposition, merger, or other material transaction. Without the full disclosure, I cannot confidently classify this as ma_activity and must default to other_material pending complete information.
View raw filing on EDGAR →
NOCERA, INC.
Other material
confidence 72%
filed 2026-05-21
Item 8.01
Nocera entered into a Strategic Advisory Agreement with Phoenix MGMT & Consulting LLC involving $150,000 initial retainer plus $50,000 monthly fees, quarterly equity grants, and transaction-based fees (5% of M&A value). While this involves equity issuance and advisory services, it does not fit cleanly into exec_compensation (no named executive officer compensation), dilutive_issuance (not a primary capital raise), or ma_activity (advisory agreement, not an M&A transaction itself). The material advisory relationship and equity commitment warrant disclosure as a significant material event outside the standard taxonomy.
View raw filing on EDGAR →
Z Squared Inc.
Other material
confidence 65%
filed 2026-05-21
Item 7.01
Z Squared Inc. announced a Phase 1 plan to reach 100 MW of AI-ready infrastructure capacity for inference workloads via press release on May 19, 2026. This disclosure under Item 7.01 (Regulation FD Disclosure) represents a material business development or strategic initiative that would affect a reasonable investor's assessment of the company's growth trajectory and capital deployment plans, but does not fit neatly into the more specific event categories (not an earnings release, M&A activity, executive change, or financial restatement). The announcement of significant infrastructure expansion capacity is material to investors evaluating the company's operational strategy and competitive positioning.
View raw filing on EDGAR →
Fulgent Genetics, Inc.
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The disclosure announces release of interim Phase 2 clinical trial data for FID-007 in combination with cetuximab for head and neck squamous cell carcinoma. While clinical trial results can be material to biotech/pharma investors, this filing lacks specificity about the trial outcomes, efficacy metrics, or clinical significance—it merely announces that an abstract was "released" without disclosing the actual results. This appears to be a clinical milestone announcement rather than a traditional earnings release or material event with clear financial/operational impact, warranting classification as other_material.
View raw filing on EDGAR →
Bioventus Inc.
Other material
confidence 75%
filed 2026-05-21
Item 7.01
The FDA reclassified Bioventus's Exogen bone growth stimulator from Class III to Class II, triggering CMS updates to Medicare reimbursement rates effective May 18, 2026. While the company states it does not presently expect a material impact on 2026 results and is reiterating guidance, the disclosure acknowledges potential long-term impacts and notes that "further changes by CMS...could require the Company to revise its financial outlook." This regulatory change affecting a core product's reimbursement is material to investors, though it does not fit neatly into the more specific event categories (not a restatement, impairment, or covenant breach, but a significant regulatory development with acknowledged future financial uncertainty).
View raw filing on EDGAR →
Federal Home Loan Bank of New York
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The filing discloses a dividend declaration by the FHLBNY Board of Directors for Q1 2026, announced via a President's Report to members. While dividend declarations are material to shareholders/members, this does not fit the earnings_release category (which typically involves comprehensive financial results) nor any other specific event type. The disclosure is material to members' assessment of the institution's capital distribution policy and financial health, warranting classification as other_material.
View raw filing on EDGAR →
Federal Home Loan Bank of New York
Other material
confidence 65%
filed 2026-05-21
Item 2.03
This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint-and-several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details in the provided text, combined with the general explanatory tone, suggests this may be a routine periodic disclosure rather than a discrete material event triggering Item 2.03. Classified as other_material because the disclosure addresses material financial obligations but does not fit cleanly into covenant_breach or other specific event categories.
View raw filing on EDGAR →
TPG Twin Brook Capital Income Fund
Other material
confidence 65%
filed 2026-05-21
Item 7.01
This Item 7.01 disclosure presents portfolio commentary and performance metrics for TCAP as of March 31, 2026, including year-to-date and trailing twelve-month returns (2.5% and 10.3% respectively), portfolio composition statistics, and market analysis. While the disclosure contains material performance information relevant to investors in the fund, it does not fit neatly into the specific event categories (e.g., it is not an earnings release with formal financial statements, nor does it announce a specific corporate action like M&A, executive changes, or covenant breaches). The commentary is primarily informational and forward-looking rather than announcing a discrete material event, making "other_material" the most appropriate classification for this portfolio update disclosure.
View raw filing on EDGAR →
Blue Owl Capital Corp
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The Company entered into an underwriting agreement on May 18, 2026 for the issuance and sale of Notes pursuant to an effective Form N-2 shelf registration. While this represents a material capital-raising transaction, the disclosure does not clearly indicate whether this is a debt or equity issuance, the amount raised, or the specific terms. The reference to "Notes" suggests debt securities, but the lack of quantitative detail and the Item 8.01 placement (rather than Item 1.01 for M&A or Item 3.02 for equity issuances) makes the most appropriate classification "other_material" rather than a more specific event type.
View raw filing on EDGAR →
Direct Digital Holdings, Inc.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The filing discloses a material change in reportable segments (from two segments—buy-side and sell-side—to one consolidated digital marketing segment) and a 4-to-1 reverse stock split effective April 27, 2026. While the company explicitly states this is "not an amendment to, or a restatement of, the 2025 Form 10-K," the recast financial statements and segment restructuring would affect a reasonable investor's understanding of the company's operational structure and historical financial performance. This does not fit the specific restatement category (which typically involves non-reliance on previously issued statements), but the segment realignment and reverse split are material corporate events that warrant disclosure.
View raw filing on EDGAR →
HawkEye 360, Inc.
Other material
confidence 65%
filed 2026-05-21
Item 1.02
The filing discloses termination of two material loan agreements (Senior Term Loan with Silicon Valley Bank and Mezzanine Loan with First-Citizens Bank) following full repayment on May 18, 2026, with release of all security interests. While this represents a significant deleveraging event material to investors, it does not fit cleanly into the standard taxonomy categories—it is neither a covenant breach, M&A activity, nor a going-concern disclosure, but rather a positive debt elimination event that warrants classification as other_material.
View raw filing on EDGAR →
HawkEye 360, Inc.
Other material
confidence 45%
filed 2026-05-21
Item 2.03
Item 2.03 discloses creation of a direct financial obligation, but the actual substance is incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific event type cannot be determined with confidence. Item 1.01 typically covers material agreements (M&A, debt, significant contracts), so this could be ma_activity, covenant_breach, or another obligation type. Marking as other_material pending visibility into the referenced Item 1.01 disclosure.
View raw filing on EDGAR →
Talen Energy Corp
Other material
confidence 72%
filed 2026-05-21
Item 1.01
Talen Energy amended its credit agreement on May 20, 2026, repricing three facilities totaling approximately $2.585 billion (Initial Term B: $846M, 2024-1 Incremental Term B: $839M, Revolving: $900M) and extending the maturity of the Initial Term B Facility from May 2030 to November 2032. While this is a material definitive agreement under Item 1.01, it does not fit cleanly into the M&A activity category—it is a refinancing/repricing of existing debt rather than an acquisition, disposition, merger, or change of control. The amendment reduces interest margins (ABR margin from unspecified to 0.75%/0.50%, Term SOFR margin to 1.75%/1.50%) and extends maturity, which is material to investors assessing the company's capital structure and debt obligations, but the event is primarily a debt restructuring rather than a discrete M&A transaction.
View raw filing on EDGAR →
ADVANCED DRAINAGE SYSTEMS, INC.
Other material
confidence 72%
filed 2026-05-21
Item 7.01
The disclosure describes a "Segment Realignment" following the NDS acquisition, where ADS consolidated reportable segments from "Infiltrator" into "Stormwater and Wastewater" and changed the profitability metric from adjusted gross profit to Adjusted EBITDA. While segment restatements and metric changes are material to investors assessing operational performance, this does not fit the specific restatement category (Item 4.02 language is absent—the company explicitly states it "does not amend or restate any of the Company's previously issued financial statements"). The realignment is disclosed under Item 7.01 (Regulation FD Disclosure) as supplemental information, making it a material disclosure that falls outside the more specific event categories.
View raw filing on EDGAR →
ADVANCED DRAINAGE SYSTEMS, INC.
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The disclosure announces Board approval of a cash dividend of $0.20 per share payable June 15, 2026. While dividend declarations are routine corporate actions, this is material to investors as it affects shareholder returns and cash flow. However, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or other defined event types), warranting classification as other_material.
View raw filing on EDGAR →
BBCMS Mortgage Trust 2026-5C41
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This Item 8.01 discloses the issuance and sale of approximately $472.9 million in commercial mortgage pass-through certificates by BBCMS Mortgage Trust 2026-5C41, a securitization vehicle. While the filing describes the transaction structure, underwriters, and credit risk retention compliance under Regulation RR, it does not fit neatly into the standard 8-K event taxonomy (e.g., not an earnings release, M&A activity, restatement, or going-concern disclosure). The transaction is material to investors in the certificates and the registrant's stakeholders, but the disclosure is primarily informational about a completed securitization closing rather than a discrete corporate event triggering a specific Item category.
View raw filing on EDGAR →
ARC Group Acquisition I Corp.
Other material
confidence 65%
filed 2026-05-21
The filing discloses that ARC Group Acquisition I Corp announced the commencement of separate trading of its unit components (Class A ordinary shares, warrants, and rights) on NASDAQ effective May 28, 2026. This is a structural capital markets event following the company's recent IPO completion (May 5-7, 2026), but does not fit neatly into the standard taxonomy categories. While material to investors as it affects trading mechanics and liquidity of the company's securities, it is neither an earnings release, executive change, M&A activity, nor a financial restatement or impairment.
View raw filing on EDGAR →
Wellgistics Health, Inc.
Other material
confidence 65%
filed 2026-05-21
The filing discloses a shareholder letter regarding "strategy overview and business update" under Item 8.01 (Other Events). Without access to the actual letter content (Exhibit 99.1), the materiality and specific nature of the update cannot be determined with certainty. However, a formal shareholder letter on strategy and business update filed via 8-K suggests material developments that would affect investor assessment, warranting classification as other_material rather than a more specific event type.
View raw filing on EDGAR →
Ocean Power Technologies, Inc.
Other material
confidence 65%
filed 2026-05-21
The filing discloses under Item 8.01 (Other Events) that Ocean Power Technologies announced an expansion in its global deployment footprint across U.S. government, international, and research customers via press release. While the specific details of the expansion are not provided in the 8-K body itself, the announcement of expanded deployment across government and international customers could be material to investors assessing the company's growth trajectory and market reach. However, without the full press release text, the precise materiality and nature of the event cannot be definitively categorized into a more specific event type, warranting classification as other_material.
View raw filing on EDGAR →
Immix Biopharma, Inc.
Other material
confidence 72%
filed 2026-05-21
The filing discloses interim clinical trial results from the Phase 2 NEXICART-2 trial showing that all four MRD-negative relapsed/refractory AL Amyloidosis patients have converted to complete response (CR), with a 95% CR rate (19/20) across the first 20 patients and no relapses observed. While this is positive clinical progress for a biopharmaceutical company's lead candidate, it does not fit neatly into the standard event taxonomy—it is neither an earnings release (no financial results), nor a material impairment, litigation, M&A activity, or executive change. The disclosure is material to investors assessing the company's pipeline and regulatory prospects, but the event is best classified as other_material given the clinical-trial-update nature of the announcement.
View raw filing on EDGAR →
VIDA Global Inc.
Other material
confidence 65%
filed 2026-05-21
The filing discloses announcement of tokenized equity listing on xStocks via press release (Exhibit 99.1), filed under Item 7.01 (Regulation FD Disclosure). This represents a material corporate development—the introduction of a blockchain-based equity instrument—that does not fit cleanly into standard 8-K categories (not M&A, not earnings, not an executive change). The tokenization of equity is a novel capital structure event that would affect investor assessment of the company's business model and equity structure.
View raw filing on EDGAR →
Rent the Runway, Inc.
Other material
confidence 65%
filed 2026-05-21
Item 7.01
The Item 7.01 disclosure reaffirms FY2026 guidance and references an ongoing CEO and CFO search process with risks of "regrettable attrition" and Board transition. While the primary action disclosed is guidance reaffirmation (routine), the forward-looking statements emphasize material risks tied to executive leadership transitions and management continuity. The filing does not explicitly disclose a specific departure or appointment, but the emphasis on search processes and transition risks suggests underlying executive changes that may be material to investors assessing management stability.
View raw filing on EDGAR →
TANDEM DIABETES CARE INC
Other material
confidence 75%
filed 2026-05-21
Item 3.03
The filing discloses stockholder-approved amendments to the Certificate of Incorporation that materially modify shareholder rights and governance protections, including removal of directors with or without cause and limitation of officer liability. While this is a governance matter affecting the rights of security holders, it does not fit neatly into the more specific event categories (it is not a shareholder vote result per se, but rather the implementation of amendments approved at a shareholder meeting). The amendments are material to investors as they alter fundamental governance and liability protections, warranting disclosure under Item 3.03.
View raw filing on EDGAR →
Apyx Medical Corp
Other material
confidence 65%
filed 2026-05-21
Item 8.01
Apyx Medical announced publication of clinical data in a peer-reviewed journal (Aesthetic Surgery Journal Open Forum) demonstrating efficacy for cellulite and skin laxity treatment. While this is a positive clinical validation event relevant to the company's product portfolio and market positioning, it does not fit neatly into the more specific event categories (not earnings, M&A, litigation, impairment, etc.). The disclosure is material to investors assessing the company's clinical evidence base and competitive standing in aesthetic medicine, but the ambiguity about whether this constitutes a "material" event versus routine clinical publication reporting warrants moderate confidence.
View raw filing on EDGAR →
Energy 11, L.P.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The filing discloses a special cash distribution of $0.12 per common unit (approximately $4.6 million) approved by the General Partner in addition to scheduled monthly distributions. While routine distributions may not be material, the special distribution—triggered by the Partnership's debt-free status, elevated market prices, and operational cash flow—represents a material capital allocation decision that would affect a reasonable investor's assessment of the Partnership's financial position and distribution policy. This does not fit neatly into the standard taxonomy categories and is best classified as other_material.
View raw filing on EDGAR →
BioCardia, Inc.
Other material
confidence 75%
filed 2026-05-21
Item 7.01
BioCardia disclosed positive preliminary clinical trial results for CardiAMP Cell Therapy presented at a major medical conference (Euro PCR), showing safety (no major adverse cardiac events) and efficacy outcomes (179-second improvement in exercise tolerance, 82% reduction in angina episodes at six months through two-year follow-up). While this is clinical trial data rather than financial results or a traditional earnings release, the positive efficacy and safety findings for a lead therapeutic candidate are material to investors' assessment of the company's pipeline and commercial prospects. This does not fit neatly into the earnings_release category (which typically refers to financial results) but represents a material clinical milestone disclosure.
View raw filing on EDGAR →
Charlie's Holdings, Inc.
Other material
confidence 45%
filed 2026-05-21
Item 1.01
Item 1.01 discloses entry into a material definitive agreement but provides no substantive details—only a cross-reference to Item 3.02. Without access to Item 3.02's content, the specific nature of the agreement cannot be determined. The cross-reference suggests the agreement may involve a dilutive issuance (Item 3.02 typically covers unregistered equity sales), but this cannot be confirmed from Item 1.01 alone. Classified as other_material pending visibility of the referenced section.
View raw filing on EDGAR →
BROADRIDGE FINANCIAL SOLUTIONS, INC.
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The disclosure announces a quarterly cash dividend declaration of $0.975 per share, which is a material capital allocation decision affecting shareholder returns. While dividend declarations are routine for established dividend-paying companies, this represents a material event to investors assessing the company's financial health and shareholder value distribution. It does not fit the more specific event categories (earnings, M&A, executive changes, etc.) and is best classified as other_material.
View raw filing on EDGAR →
Federal Home Loan Bank of Dallas
Other material
confidence 65%
filed 2026-05-21
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $2.37 billion across multiple tranches with varying maturities (ranging from 8/20/2026 to 5/26/2056) and rate structures. While Item 2.03 typically signals covenant_breach or material debt obligations, the filing itself explicitly states "the Bank has not made a judgment as to the materiality of these consolidated obligation bonds," and the disclosure is routine debt issuance activity for a Federal Home Loan Bank. The event is material to investors as a significant funding activity, but does not fit cleanly into the more specific event categories (no covenant breach, no going concern, no impairment), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
Federal Home Loan Bank of Indianapolis
Other material
confidence 65%
filed 2026-05-21
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling $260 million with maturities ranging from one to four years. While Item 2.03 typically covers debt covenant breaches or off-balance sheet arrangements, this disclosure is fundamentally about the creation of direct financial obligations through bond issuances. The materiality is clear given the substantial principal amounts and multi-year maturities, but the event does not fit cleanly into the covenant_breach category (no breach is disclosed) and lacks the specific characteristics of other defined event types, warranting classification as other_material.
View raw filing on EDGAR →
Federal Home Loan Bank of Atlanta
Other material
confidence 75%
filed 2026-05-21
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $505 million across five separate debt securities issued in May 2026. While Item 2.03 is technically designed for covenant_breach events, the filing's explicit focus on debt issuance—a material financing activity for a Federal Home Loan Bank—does not fit cleanly into the covenant_breach category. The disclosure is material to investors assessing the Bank's capital structure and funding activities, but the event itself (routine debt issuance by a government-sponsored enterprise) lacks the distress signal of a covenant violation or the transformative nature of M&A activity.
View raw filing on EDGAR →
Federal Home Loan Bank of Boston
Other material
confidence 75%
filed 2026-05-21
Item 2.03
This Item 2.03 disclosure reports the issuance of consolidated obligations (bonds and discount notes) totaling approximately $293 million across seven separate debt securities issued in May 2026. While Item 2.03 typically signals covenant_breach or direct financial obligations arising from adverse events, this filing discloses routine debt issuances by a Federal Home Loan Bank to fund operations—a standard capital markets activity. The disclosure is material to investors as it reflects the Bank's funding activities and debt structure, but does not fit the specific event types (covenant_breach, ma_activity, or dilutive_issuance) as cleanly as other_material, since these are consolidated obligations jointly backed by all 11 FHLBanks rather than a discrete triggering event or breach.
View raw filing on EDGAR →
Federal Home Loan Bank of Chicago
Other material
confidence 75%
filed 2026-05-21
Item 2.03
This Item 2.03 disclosure reports the issuance of consolidated obligations (bonds and discount notes) totaling approximately $781 million across multiple tranches with varying maturities and coupon rates. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although consolidated obligations issuance is material to the Bank, we have not made a judgment as to the materiality of any particular consolidated obligation or obligations." The disclosure is routine for a Federal Home Loan Bank's ordinary course debt issuance operations, not a discrete material event like a covenant breach or going-concern issue. This is best classified as other_material rather than covenant_breach, as it represents standard debt capital-raising activity rather than a triggering financial stress event.
View raw filing on EDGAR →
Federal Home Loan Bank of Pittsburgh
Other material
confidence 65%
filed 2026-05-21
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and referencing Schedule A for specific debt instruments. This does not fit cleanly into covenant_breach (no violation alleged) or the more specific debt-related categories, making other_material the most appropriate classification for this regulatory debt disclosure.
View raw filing on EDGAR →